Due to the oxidative properties of povidone-iodine, its traces can lead to false-positive results of some types of studies for the detection of latent blood in feces, as well as blood or glucose in the urine.
During the application of povidone iodine, iodine absorption by the thyroid gland may decrease, which may affect the results of some diagnostic studies (eg, thyroid scintigraphy, determination of protein-bound iodine, measurements with radioactive iodine), and may interact with iodine preparations used for the treatment of diseases of the thyroid gland. To obtain undistorted results of thyroid scintigraphy after long-term povidone-iodine therapy, it is recommended to withstand a sufficiently long period of time without this drug.
In case of thyroid dysfunction, the drug can be used only as directed by a physician. If symptoms of hyperthyroidism occur during the course of treatment, the function of the thyroid gland should be checked.It is necessary to monitor the function of the thyroid gland in newborns and breast-fed infants whose mothers used Betadine®.
Caution should be observed with regular use of the drug in patients with previously diagnosed kidney failure. Betadine should be avoided on a regular basis® in patients receiving lithium preparations.
The use of povidone iodine is allowed from the newborn period, but taking into account the form of release - vaginal suppositories, the drug is not recommended for use before 8 years and be careful when introducing virgins.
Coloring on the skin and tissues is easily washed off with water. After contact with the drug, avoid contact with the product in the eye
Suppositories have a spermicidal effect, and therefore it is not recommended to use them in persons planning a pregnancy.
During the use of suppositories, the use of sanitary napkins can be recommended.